Rx (Prescription Medicine)
USD $ 16.00
Invista 70mg Tablet 是一种含有活性成分 Vildagliptin 的药物。它属于一类称为二肽基肽酶-4（DPP-4）抑制剂的药物。Vildagliptin 通过增加体内肠激肽激素的水平发挥作用。这些激素有助于调节血糖水平，通过刺激胰腺分泌更多胰岛素并减少肝脏在餐后产生的糖分来实现。这种双重作用有助于降低糖尿病患者的血糖水平。Invista 70mg Tablet 为改善2型糖尿病患者的血糖控制而作为饮食和运动的辅助治疗。它可单独使用，也可与其他降糖药物如二甲双胍、磺酰脲类或二噻嗪类联合使用。通常剂量为每日一次 70mg 片。然而，具体剂量应由医疗专业人员根据患者的个体需求和反应来确定。常见的不良反应可能包括低血糖（低血糖症）、头痛、头晕和胃肠道不适。重要的是向医生报告任何既往疾病，尤其是心衰，以及您正在服用的其他药物。请将 Invista 70mg Tablet 存放于室温，远离潮湿和热源，并放在儿童不易触及的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength |
其他品牌的 Dasatinib 70 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
